These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 16580578

  • 1. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A, Wu L, Wang R, de Champlain J.
    Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
    [Abstract] [Full Text] [Related]

  • 2. Impact of α-lipoic acid on liver peroxisome proliferator-activated receptor-α, vascular remodeling, and oxidative stress in insulin-resistant rats.
    El Midaoui A, Lungu C, Wang H, Wu L, Robillard C, Deblois D, Couture R.
    Can J Physiol Pharmacol; 2011 Oct; 89(10):743-51. PubMed ID: 21919742
    [Abstract] [Full Text] [Related]

  • 3. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W, De Keyzer D, Pelat M, Verhamme P, Ganame J, Bielicki JK, Mertens A, Quarck R, Benhabilès N, Marguerie G, Mackness B, Mackness M, Ninio E, Herregods MC, Balligand JL, Holvoet P.
    Circulation; 2004 Nov 16; 110(20):3259-69. PubMed ID: 15533870
    [Abstract] [Full Text] [Related]

  • 4. Effects of PPAR-gamma knock-down and hyperglycemia on insulin signaling in vascular smooth muscle cells from hypertensive rats.
    Pandey NR, Benkirane K, Amiri F, Schiffrin EL.
    J Cardiovasc Pharmacol; 2007 Jun 16; 49(6):346-54. PubMed ID: 17577098
    [Abstract] [Full Text] [Related]

  • 5. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
    Li L, Gao PJ, Xi R, Wu CF, Zhu DL, Yan J, Lu GP.
    Clin Exp Pharmacol Physiol; 2008 Dec 16; 35(12):1471-6. PubMed ID: 18759864
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
    Wu Y, Zhao XD, Zhuang Z, Xue YJ, Cheng HL, Yin HX, Shi JX.
    Brain Res; 2010 Mar 31; 1322():102-8. PubMed ID: 20132800
    [Abstract] [Full Text] [Related]

  • 7. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
    Shen X, Li H, Li W, Wu X, Ding X.
    Mol Cell Endocrinol; 2012 Nov 05; 363(1-2):27-35. PubMed ID: 22820128
    [Abstract] [Full Text] [Related]

  • 8. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H, Takeshita S, Kimura C, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Mutoh S.
    Diabetes Obes Metab; 2007 May 05; 9(3):369-78. PubMed ID: 17391165
    [Abstract] [Full Text] [Related]

  • 9. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
    Koçak G, Aktan F, Canbolat O, Ozoğul C, Elbeğ S, Yildizoglu-Ari N, Karasu C, ADIC Study Group--Antioxidants in Diabetes-Induced Complications.
    Diabetes Nutr Metab; 2000 Dec 05; 13(6):308-18. PubMed ID: 11232755
    [Abstract] [Full Text] [Related]

  • 10. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
    Chakrabarti R, Misra P, Vikramadithyan RK, Premkumar M, Hiriyan J, Datla SR, Damarla RK, Suresh J, Rajagopalan R.
    Eur J Pharmacol; 2004 May 03; 491(2-3):195-206. PubMed ID: 15140637
    [Abstract] [Full Text] [Related]

  • 11. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production.
    Midaoui AE, Elimadi A, Wu L, Haddad PS, de Champlain J.
    Am J Hypertens; 2003 Mar 03; 16(3):173-9. PubMed ID: 12620694
    [Abstract] [Full Text] [Related]

  • 12. Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes.
    El Midaoui A, de Champlain J.
    J Hypertens; 2005 Mar 03; 23(3):581-8. PubMed ID: 15716700
    [Abstract] [Full Text] [Related]

  • 13. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH, McNamara LA, Wu MS, Muise ES, Tan Y, Wood HB, Meinke PT, Thompson JR, Doebber TW, Berger JP, McCann ME.
    Eur J Pharmacol; 2008 Apr 14; 584(1):192-201. PubMed ID: 18346728
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J, Fang NY, Gao PJ, Wu LY, Han WQ, Guo SJ, Shen WL, Zhu DL.
    Clin Exp Pharmacol Physiol; 2008 Jan 14; 35(1):72-7. PubMed ID: 18047631
    [Abstract] [Full Text] [Related]

  • 15. Effect of chronic inhibition of nitric oxide on hypertension, insulin resistance, and cardiovascular remodeling in glucose-fed rats.
    Pilon M, Wu R, Huot-Marchand JE, deBlois D, Champlain Jd, Couture R.
    J Cardiovasc Pharmacol; 2009 May 14; 53(5):405-13. PubMed ID: 19333132
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
    Wakino S, Hayashi K, Kanda T, Tatematsu S, Homma K, Yoshioka K, Takamatsu I, Saruta T.
    Circ Res; 2004 Sep 03; 95(5):e45-55. PubMed ID: 15308580
    [Abstract] [Full Text] [Related]

  • 17. Impaired expression of PPAR gamma protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats.
    Xiong C, Mou Y, Zhang J, Fu M, Chen YE, Akinbami MA, Cui T.
    Life Sci; 2005 Oct 28; 77(24):3037-48. PubMed ID: 15970297
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
    Sun L, Ke Y, Zhu CY, Tang N, Tian DK, Gao YH, Zheng JP, Bian K.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2305-11. PubMed ID: 19080338
    [Abstract] [Full Text] [Related]

  • 19. [Expression of peroxisome proliferator-activated receptors Y changes with age in vascular smooth muscle cells of spontaneously hypertensive rat].
    Di ZL, Niu XL, Wei J, Li YQ, Chen GL, Wang NP.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar 20; 37(2):204-7. PubMed ID: 16608075
    [Abstract] [Full Text] [Related]

  • 20. Effects of rosiglitazone (a peroxysome proliferator-activated receptor gamma agonist) on the blood pressure and aortic structure in metabolically programmed (perinatal low protein) rats.
    Torres TS, D'Oliveira Silva G, Aguila MB, de Carvalho JJ, Mandarim-De-Lacerda CA.
    Hypertens Res; 2008 May 20; 31(5):965-75. PubMed ID: 18712052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.